Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지

Optimal Radiation Therapy Field for Malignant Astrocytoma and Glioblastoma Multiforme

악성 성상세포종 및 교모세포종의 적정 방사선 조사 영역에 대한 고찰

  • Cho, Heung-Lae (Department of Radiation Oncology, Pusan Paik Hospital, Inje University College of Medicine) ;
  • Choi, Young-Min (Department of Radiation Oncology, Pusan Paik Hospital, Inje University College of Medicine)
  • 조홍래 (인제대학교 의과대학 부산백병원 방사선종양학과) ;
  • 최영민 (인제대학교 의과대학 부산백병원 방사선종양학과)
  • Published : 2002.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : This study was peformed to determine the optimal radiation therapy field for the treatment of malignant astrocytoma and glioblastoma multiforme. Materials and Methods : From Jan. 1994 to Mar. 2000, 21 patients with malignant astrocytoma and glioblastoma multiforme, confirmed as recurrent by follow up MRI after surgery and radiation therapy, were analyzed. The distance from the margin of the primary lesion to the recurrent lesion was measured. The following factors were analyzed to Investigate the influence of these factors to recurrence pattern; tumor size, degree of edema, surgical extent, gamma knife radiosurgery and multiple lesions. Results : Among the 21 patients, 18 $(86\%)$ were recurred within 2 cm from the primary lesion site. 12 within 1 cm, 6 between 1 and 2 cm. The other 3 patients all with multiple lesions, were recurred at 3, 4, 5 cm, from the primary lesion site. The recurrence pattern was not influenced by the factors of tumor size, extent of edema, surgical extent, or gamma knife radiosurgery. However, patients with multiple lesions showed a tendency of recurrence at sites further from the primary lesion. Conclusions : Most $(86\%)$ of the recurrences of malignant astrocytoma and glioblastoma multiforme occurred within 2 cm from the primary lesion site. The width of treatment field does not need to be changed according to tumor size, degree of edema, surgical extent, or gamma knife radiosurgery. However, the treatment field for multiple lesions appears to be wider than that for a single lesion.

목적 : 본 연구의 목적은 악성 성상세포종 및 교모세포종 환자들의 방사선 치료 시 가장 적절한 조사 영역을 알아 보고자 시행하였다. 대상 및 방법 : 1994년 1월부터 2000년 3월까지 악성 성상세포종 및 교모세포종으로 진단되어 수술 및 방사선 치료를 받은 후 MRI로 추적관찰이 시행된 환자 중 재발이 확인된 21 명을 대상으로 분석하였다. 원발 병소 바깥 경계에서부터 처음 재발이 확인된 병소까지의 거리를 측정하였다. 그 외에 종양의 크기, 부종의 정도, 수술 절제의 범위, 감마나이프를 이용한 정위방사선수술, 다발성 병변 등이 재발 양상에 미치는 영향에 대하여 분석을 하였다. 결과 : 총 21명 중 18명$(86\%)$이 2 cm 이내에서 재발을 하였다. 이들 중 1 cm 이내가 12명, $1\~2\;cm$ 사이의 재발이 6명이었다. 나머지 3명의 재발은 3 cm, 4 cm, 5 cm, 떨어져서 각각 재발을 하였다. 2 cm 이상 떨어져 재발한 3명은 모두 다발성 병변이 있는 환자였다. 종양의 크기, 부종의 범위, 수술 절제의 범위, 감마나이프 시행 유무에 따른 재발의 양상에 차이가 없었다. 다만 다발성 병변일 경우 더 멀리서 재발하는 경향을 보였다. 결론 : 악성 성상세포종 및 교모세포종에서 재발 양상은 원발 병소 준위의 2 cm 이내 재발이 주 재발 양상이었다. 방사선 조사영역의 넓이는 부종의 범위나, 병소의 크기, 감마 나이프 수술 등에 따라 더 넓힐 필요는 없는 것으로 판단된다. 그러나 다발성 병변의 경우에는 단일 병소보다 더 넓은 조사 범위가 필요할 것으로 생각된다.

Keywords

References

  1. Chang CH, Horton J, Schoenfeld D, et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A Joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 1983;53:999-1007 https://doi.org/10.1002/1097-0142(19840215)53:4<999::AID-CNCR2820530429>3.0.CO;2-N
  2. Kristianse K, Hagen S, Kollevold T, et al. Combined modality therapy of operated astrocytomas grade 3 and 4: A prospective multi-center trial of the Scandinavian Glioblastoma Study Group. Cancer 1981;47:649-652 https://doi.org/10.1002/1097-0142(19810215)47:4<649::AID-CNCR2820470405>3.0.CO;2-W
  3. McShan DL, Fraass BA, Lichter AS. Full integration of the beam's eye view concept into computerized treatment planning. Int J Radiat Oncol Biol Phys 1990;18:1485-1494 https://doi.org/10.1016/0360-3016(90)90325-E
  4. Walker MD, Strike TA, Sheline GE. An analysis of doseeffect relationship in the radiotherapy of malignant glioblastomas. Int J Radiat Oncol Biol Phys 1979;5:1725-1731
  5. Gutin PH, Prados MD, Philips TL. et al. External irradiation followed by and interstitial high activity iodine-125 implant 'boost' in the initial treatment of malignant gliomas; NCOG Study 6G-82-2 . Int J Radiat Oncol Biol Phys 1991;21:601-606
  6. Concannon JP, Kramer S, Berry R. The extent of intracranial glioma at autopsy and its relationhip to techniques used in radiation therapy of brain tumors. Am J Roentgeol 1960;84:99-107
  7. Salazar OM, Rubin P. The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. Int J Radiat Oncol Biol Phys 1976;1:627-637 https://doi.org/10.1016/0360-3016(76)90144-9
  8. Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980;30:907-911
  9. Bachir R, Hochberg F, Oot R. Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields. Neurosurgery 1988;23:27-30 https://doi.org/10.1227/00006123-198807000-00006
  10. Wallner KE, Galicich JH, Krol G, et al. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989;16:1405-1409 https://doi.org/10.1016/0360-3016(89)90941-3
  11. Gaspar LE, Fisher BJ, Macdonald DR, et al. Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys 1992;24:55-57 https://doi.org/10.1016/0360-3016(92)91021-E
  12. Garden AS, Maor MH Yung WKA, et al. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol 1991;20:99-110 https://doi.org/10.1016/0167-8140(91)90143-5
  13. Liang BC, Thornton AF, Sandler HM, et al. Malignant astrocytomas: Focal tumor recurrence after focal external beam radiation therpav. J Neurosurg 1991;75:559-563 https://doi.org/10.3171/jns.1991.75.4.0559
  14. Agbi CB, Bernstein M, Laperriere N, et al. Patterns of recurrence of malignant astrocytoma following stereotactic interstitial brachytherapy with iodine-125 implants. Int J Radiat Oncol Biol Phys 1992;23:321-326 https://doi.org/10.1016/0360-3016(92)90748-7
  15. Bleehan NM, Stenning SP. A medical research council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer 1991;64:769-774
  16. Garden AS, Maor MH, Yung WKA, et al. Outcome and patterns of failure following limited volume irradiation for malignant astrocytomas. Radiother Oncol 1991;20:99-110 https://doi.org/10.1016/0167-8140(91)90143-5
  17. Seither RB, Jose B, Paris KJ, et al. Results of irradiation in patients with high grade gliomas evaluated by magnetic resonance imaging. Am J Clin Oncol 1995;18:297-299 https://doi.org/10.1097/00000421-199508000-00005
  18. Kelly PJ, Daumas-Duport C, Kispert DB. Imaging based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurgery 1987;66:865-874 https://doi.org/10.3171/jns.1987.66.6.0865
  19. Pirzkall A, McKnight TR, Graves EE, et al. MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 2001;50:915-928Burger PC, Heinz RE, Shibata T, et al https://doi.org/10.1016/S0360-3016(01)01548-6
  20. Halperin EC, Bentel G, Heinz ER, et al. Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biolol Phys 1989; 17:1347-1350 https://doi.org/10.1016/0360-3016(89)90548-8
  21. Radany EH, Sandler HM, Haken T, et al. 3 D conformal radiotherapy for malignant astrocytomas: dose escalation to 90 Gy. Int J Radiat Oncol Biol Phys 1997;39:140
  22. Lee SW, Fraass BA, Marsh LH et al. Patterns of failure following high-dose 3-D conformal radiotherapy for highgrade astrocytomas:a quantitative dosimetric study Int J Radiat Oncol Biol Phys 1999;43:79-88
  23. Sneed PK, Guin PH, Larson DA, et al. Patterns of recurrence of Glioblastoma multiforme after external irradiation followed by implant boost. Int J Radlat Oncol Biol Phys 1994;29:719-727 https://doi.org/10.1016/0360-3016(94)90559-2
  24. Mehta MP, Masciopinto M, Rozental J, et al. Stereotactic radiosurgery for glioblastoma.multiforme : report of a prospective study evaluating prognostic factors and analyzing longterm survival advantage. Int J Radiat Oncol Biol Phys 1994;30:541-549
  25. Nakagawa K, Yukimasa A, Fujimaki T, et al. High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme Int J Radiat Oncol Biol Phys 1998;40:1141-1149
  26. Kondziolka D, Lunsford LD, Claassen D. Radiobiology of radiosurgery: Part II. The rat C6 glioma model. Neurosurgery 1992;31:280-288 https://doi.org/10.1227/00006123-199208000-00013